Edward Fanning, Jr. and David Kott have submitted an amicus curiae brief to the New Jersey Appellate Division on behalf of the HealthCare Institute of New Jersey in In re: Accutane Litigation. The brief addresses the New Jersey Product Liability Act’s presumption of adequacy that applies to warnings on FDA-approved medicines.
9.19.2017